GeneDx Holdings CorpWGS
Price$70.96Intrinsic value$70.521% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $70.52median of 2 methodsbased on filings through 30 Jun 2026
Market Price $70.96Price as of 1 Oct 2026
Margin of Safety -0.6%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -15.0% (near-term consensus, capped) · years 2–5: 16.6%/yr (balance of the path).9.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 615.2%Yr 713.8%Yr 812.3%Yr 910.9%Yr 109.5%
16.6% → 9.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.8%Yr 128.2%Yr 137.5%Yr 146.9%Yr 156.2%Yr 165.6%Yr 174.9%Yr 184.3%Yr 193.6%Yr 203.0%
9.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 12.3%
Volatility vs market (adjusted beta)1.64

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetGeneDx Holdings CorpWGSHealth Care
Valuation
P/E—
P/S6.9×
P/B12.3×
EV / Revenue7.0×
EV / EBITDA-240.3×
Profitability
Gross margin66.7%
Operating margin-56.2%
Net margin-23.4%
FCF margin-16.7%
Returns
ROE-43.5%
ROA-22.1%
ROIC—
Growth
Revenue growth (YoY)48.8%
5-yr fwd EPS growth9.5%
Financial strength
Debt / Equity0.40×
Current ratio3.30×
Altman Z-Score3.4
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.